http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0447569-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37123d1508036ffc2a5995ad43ffca22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c69a80e4addc2fe0a94f522dd2b0644
publicationDate 1991-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0447569-A1
titleOfInvention Product for the prophylaxis, diagnosis and therapy of rheumatic, autoimmune, skin and connective tissue diseases of an unknown aetiology, and methods of its manufacture and use
abstract The product is manufactured by heating together a salt, or salts, of iron (Fe) and a lipid, or lipids. Used in a topical dermal application, it is distinguished by its property of eliciting and curing lesions at asymptomatic latency-reactivation sites in which resides the causative agent of these maladies while evoking no such reaction in the rest of the skin. These maladies include systemic lupus erythematosus, vasculitis, sarcoidosis, amyloidosis, rheumatoid arthritis, osteoarthrosis, acne, comedos, psoriasis, tinea, onychia, paronychia, corns, callosities, alopecia and indolent tropical ulcers. Their prophylaxis and diagnosis in the latent stage is made feasible by this invention. n A prolonged topical dermal application of the product and the removal of the necrosed tissue of latency-reactivation sites eradicates the causative agent (primary stimulus, persistent antigen) from the skin and heals the lesions, thus arresting the progress of the malady and effecting a cure from it at that particular stage.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1260226-A1
priorityDate 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0025721-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0246734-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11709
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98527
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4577
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11709
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10255
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 29.